scispace - formally typeset
R

Rafael Violante Ortiz

Researcher at Mexican Social Security Institute

Publications -  16
Citations -  1988

Rafael Violante Ortiz is an academic researcher from Mexican Social Security Institute. The author has contributed to research in topics: Liraglutide & Overweight. The author has an hindex of 6, co-authored 14 publications receiving 1276 citations.

Papers
More filters
Journal ArticleDOI

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, +200 more
- 08 Apr 2017 - 
TL;DR: Liraglutide 3·0 mg might provide health benefits in terms of reduced risk of diabetes in individuals with obesity and prediabetes in this trial, with the limitation that withdrawn individuals were not followed up after discontinuation.
Journal ArticleDOI

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

Stefano Del Prato, +205 more
- 13 Nov 2021 - 
TL;DR: Tirzepatide versus insulin glargine was compared in adults with type 2 diabetes and high cardiovascular risk inadequately controlled on oral glucose-lowering medications.

Obesidad y diabetes tipo 2 en el niño. Una nueva epidemia

TL;DR: The Health Authorities and all society should be required to participate in educational programs at public and private levels to promote a change in lifestyle and general doctors should be aware of this new way diabetes is breaking out.